The fact that TNBC cell lines, MDA-MB-231 and MDA-MB-468, express high levels of FABP5 and are resistant to retinoid therapy suggests that by suppressing the expression level of FABP5, these subtypes of breast cancer cells can overcome RA resistance. Here, FABP5 is linked to breast carcinoma.